Clinical Trials Browser

Enrolling by invitation × OTHER × 130-nm albumin-bound paclitaxel × Clear all

NCT07310069 2025-12-30

TRANSFORM-GBC

Phase 2 Enrolling by invitation

Gastrointestinal

Gallbladder Neoplasms

NCT06901622 2025-03-30

Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma

Phase 2 Enrolling by invitation

Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma